ZION Stock Analysis: Zions Bancorporation | NASDAQ

Banks - Regional | NASDAQ, USA | Market Cap: 9.616m USD | 12M Return: 27% | US9897011071 | Charts, Fundamentals & Technical Analysis

Commercial Lending, Investment Banking, Mortgage Lending, Wealth Management
Total Rating 51
Safety 48
Buy Signal -0.33
Regional Banks
Sub-Industry Rotation: +2.9
Market Cap: 9.62B
Avg Turnover: 95.0M
Risk 3d forecast
Volatility33.5%
VaR 5th Pctl5.52%
VaR vs Median0.11%
Reward TTM
Sharpe Ratio0.94
Rel. Str. IBD63.6
Rel. Str. Peer Group41 pctl
Character TTM
Beta0.936
Beta Downside0.969
Hurst Exponent0.551
Choppyness65.1%
Drawdowns 3y
Max DD32.43%
CAGR/Max DD0.81
CAGR/Mean DD3.03
EPS (Earnings per Share) EPS (Earnings per Share) of ZION over the last years for every Quarter: "2021-09": 1.53, "2021-12": 1.26, "2022-03": 1.32, "2022-06": 1.24, "2022-09": 1.36, "2022-12": 1.88, "2023-03": 1.33, "2023-06": 1.18, "2023-09": 1.13, "2023-12": 1.3, "2024-03": 1.05, "2024-06": 1.28, "2024-09": 1.34, "2024-12": 1.34, "2025-03": 1.13, "2025-06": 1.58, "2025-09": 1.54, "2025-12": 1.76, "2026-03": 1.54, "2026-06": 1.74, "2026-09": 1.78,
EPS CAGR: 15.14%
EPS Trend: 95.4%
Last SUE: 1.50
Qual. Beats: 6
Revenue Revenue of ZION over the last years for every Quarter: 2021-09: 708, 2021-12: 756, 2022-03: 695, 2022-06: 780, 2022-09: 872, 2022-12: 988, 2023-03: 830, 2023-06: 1166, 2023-09: 1190, 2023-12: 1188, 2024-03: 1210, 2024-06: 1243, 2024-09: 1276, 2024-12: 1255, 2025-03: 1199, 2025-06: 1241, 2025-09: 1253, 2025-12: 1251, 2026-03: 1183, 2026-06: 1479, 2026-09: 1243,
Rev. CAGR: 3.85%
Rev. Trend: 79.3%
Last SUE: 0.58
Qual. Beats: 0

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +0.8% 0
Feb -0.7% 4
Mar -7.0% 47
Apr +0.1% 0
May +0.6% 4
Jun +1.4% 14
Jul -0.2% 0
Aug -3.6% 4
Sep -4.3% 28
Oct +1.8% 14
Nov +4.2% 39
Dec +0.2% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: ZION Zions Bancorporation

Zions Bancorporation (ZION) is a regional U.S. bank holding company headquartered in Salt Lake City, Utah, founded in 1873. It operates primarily across 11 western states through seven distinct bank charters, including Zions Bank, California Bank & Trust, Amegy Bank, and National Bank of Arizona. The company provides a full suite of commercial banking, small business lending, retail banking, wealth management, and capital markets/investment banking services. Its multi-brand structure reflects a growth strategy built largely through the acquisition and integration of regional banks, a common approach among U.S. regional banks seeking scale and geographic diversification while maintaining local market identity. The company rebranded from ZB, National Association to its current name in September 2018.

Headlines to Watch Out For
  • Net interest margin expansion lifts earnings amid elevated rates
  • Commercial real estate loan losses threaten credit quality
  • Deposit costs pressure margins as competition for funding intensifies
Piotroski VR-10 (Strict) 4.5
Net Income: 1.21b TTM > 0 and > 6% of Revenue
FCF/TA: 0.03 > 0.02 and ΔFCF/TA 1.66 > 1.0
NWC/Revenue: -1.08k% < 20% (prev -1.33k%; Δ 247.6% < -1%)
CFO/TA 0.03 > 3% & CFO 2.65b > Net Income 1.21b
Net Debt (-19.6b) to EBITDA (1.67b): -11.72 < 3
Current Ratio: 0.29 > 1.5 & < 3
Outstanding Shares: last quarter (145.1m) vs 12m ago -1.38% < -2%
Gross Margin: 73.04% > 18% (prev 64.81%; Δ 8.23% > 0.5%)
Asset Turnover: 5.75% > 50% (prev 5.59%; Δ 0.16% > 0%)
Interest Coverage Ratio: 1.11 > 6 (EBIT TTM 1.55b / Interest Expense TTM 1.40b)
Altman Z'' -3.53
A: -0.62 (Total Current Assets 22.9b - Total Current Liabilities 78.8b) / Total Assets 90.9b
B: 0.09 (Retained Earnings 8.07b / Total Assets 90.9b)
C: 0.02 (EBIT TTM 1.55b / Avg Total Assets 89.7b)
D: 0.09 (Book Value of Equity 7.68b / Total Liabilities 83.2b)
Altman-Z'' = -3.53 = D
What is the price of ZION shares?

As of November 20, 2026, the stock is trading at USD 62.24 with a total of 1,512,463 shares traded. Over the past week, the price has changed by -5.63%, over one month by -0.71%, over three months by -8.20% and over the past year by +27.01%.

Current recommended Stop Loss: 60.10 (which is 3.4% or 1.5 ATR below the current price).

Is ZION a buy, sell or hold?

Zions Bancorporation has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold ZION.

  • StrongBuy: 8
  • Buy: 0
  • Hold: 11
  • Sell: 2
  • StrongSell: 2

What are the forecasts/targets for the ZION price?
Analysts Target Price 72.6 16.7%
Zions Bancorporation (ZION) - Fundamental Data Overview as of 17 November 2026
Market Cap USD = 9.62b (9.62b USD * 1.0 USD.USD)
P/E Trailing = 8.1399
P/E Forward = 9.5511
P/S = 2.5547
P/B = 1.262
P/EG = 3.5373
Revenue TTM = 5.16b USD
EBIT TTM = 1.55b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 2.41b USD (from longTermDebt, last quarter)
Short Term Debt = 843.0m USD (from shortTermDebt, last quarter)
Debt = 3.26b USD (from shortLongTermDebtTotal, last quarter) + Leases 3.00m
Net Debt = -19.6b USD (calculated: Debt 3.26b - CCE 22.8b)
Enterprise Value = 9.62b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 1.11 (Ebit TTM 1.55b / Interest Expense TTM 1.40b)
EV/FCF = 3.85x (Enterprise Value 9.62b / FCF TTM 2.50b)
FCF Yield = 25.95% (FCF TTM 2.50b / Enterprise Value 9.62b)
FCF Margin = 48.39% (FCF TTM 2.50b / Revenue TTM 5.16b)
Net Margin = 23.51% (Net Income TTM 1.21b / Revenue TTM 5.16b)
Gross Margin = 73.04% ((Revenue TTM 5.16b - Cost of Revenue TTM 1.39b) / Revenue TTM)
Gross Margin QoQ = 71.52% (prev 76.67%)
Tobins Q-Ratio = 0.11 (Enterprise Value 9.62b / Total Assets 90.9b)
Interest Expense / Debt = 42.80% (Interest Expense 1.40b / Debt 3.26b)
Taxrate = 21.91% (340.0m / 1.55b)
NOPAT = 1.21b (EBIT 1.55b * (1 - 21.91%))
Current Ratio = 0.29 (Total Current Assets 22.9b / Total Current Liabilities 78.8b)
Debt / Equity = 0.42 (Debt 3.26b / totalStockholderEquity, last quarter 7.68b)
Debt / EBITDA = -11.72 (Net Debt -19.6b / EBITDA 1.67b)
Debt / FCF = -7.84 (Net Debt -19.6b / FCF TTM 2.50b)
Total Stockholder Equity = 7.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.35% (Net Income 1.21b / Total Assets 90.9b)
RoE = 16.25% (Net Income TTM 1.21b / Total Stockholder Equity 7.46b)
RoCE = 15.72% (EBIT 1.55b / Capital Employed (Equity 7.46b + L.T.Debt 2.41b))
RoIC = 9.53% (NOPAT 1.21b / Invested Capital 12.7b)
WACC = 15.02% (E(9.62b)/V(12.9b) * Re(8.78%) + D(3.26b)/V(12.9b) * Rd(42.80%) * (1-Tc(0.22)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -70.84 | Cagr: -0.62%
[DCF] Terminal Value 59.43% ; FCFF base≈1.88b ; Y1≈2.16b ; Y5≈3.17b
[DCF] Fair Price = 284.7 (EV 21.7b - Net Debt -19.6b = Equity 41.3b / Shares 144.9m; r=15.02% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.35 | EPS CAGR: 15.14% | SUE: 1.50 | # QB: 6
Revenue Correlation: 79.28 | Revenue CAGR: 3.85% | SUE: 0.58 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.53 | Chg30d=+0.07% | Revisions=-22% | Analysts=9
EPS current Year (2026-12-31): EPS=6.74 | Chg30d=+2.56% | Revisions=+81% | GrowthEPS=+15.7% | GrowthRev=+5.6%
EPS next Year (2027-12-31): EPS=6.93 | Chg30d=+1.88% | Revisions=+47% | GrowthEPS=+2.9% | GrowthRev=+3.2%
[Analyst] Revisions Ratio: +53% (up=26, down=7)